Hydroxychloroquine is being snapped up by medical systems at more than
twice the typical pace as U.S. hospitals seek to build large
inventories in anticipation of the medication's potential use in
patients with Covid-19.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/fda-lifts-curbs-on-indian-maker-of-malaria-touted-by-donald-trump-as-a-covid-counter/articleshow/74786575.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment